Patents by Inventor Qingping Jiang

Qingping Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6664043
    Abstract: The present invention is generally directed to detectable chemiluminescent acridinium ester labels having hydrophilic modifiers; to compositions, complexes and/or conjugates which include such labels; and to processes for performing bioanalytical assays for target analytes which use such labels. Assays for folate, theophylline, and tobramycin (using such labels with hydrophilic modifiers such as nonionic polyethylene glycol and polyionic spermine disulfonate and polyionic spermine dicarboxylate) are described in detail.
    Type: Grant
    Filed: July 3, 2001
    Date of Patent: December 16, 2003
    Assignee: Bayer Corporation
    Inventors: Anand Natrajan, David Sharpe, Qingping Jiang
  • Publication number: 20030211968
    Abstract: A new neuromedin U receptor, designated NMUR2 has been found, which is involved in modulation of feeding behavior in mammals. Ligands of this receptor are able to modulate eating, and weight gain. Amino acid sequences of the human and rat forms, as well as their nucleic acid sequences are given.
    Type: Application
    Filed: April 8, 2003
    Publication date: November 13, 2003
    Inventors: Qingyun Liu, Kevin R. Lynch, Andrew D. Howard, Theodore N. Mellin, Alison Strack, Leonardus H.T. Van Der Ploeg, Ruiping Wang, Qingping Jiang, David Williams
  • Publication number: 20030045716
    Abstract: The present invention is generally directed to detectable chemiluminescent acridinium ester labels having hydrophilic modifiers; to compositions, complexes and/or conjugates which include such labels; and to processes for performing bioanalytical assays for target analytes which use such labels. Assays for folate, theophylline, and tobramycin (using such labels with hydrophilic modifiers such as nonionic polyethylene glycol and polyionic spermine disulfonate and polyionic spermine dicarboxylate) are described in detail.
    Type: Application
    Filed: July 3, 2001
    Publication date: March 6, 2003
    Inventors: Anand Natrajan, David Sharpe, Qingping Jiang
  • Publication number: 20020098485
    Abstract: Disclosed is amplification of a target sequence using the activity of a replicase that quasi-autocatalytically replicates a specific replicase replicable or “replicatable” sequence, while ensuring fidelity thereof by detecting the presence of the amplified target or antitarget sequence rather than the amplified replicase replicable sequence. A method according to the invention for assaying a target nucleic acid comprising hybridizing a set of one or more amplification probes with a nucleic acid sample is provided. A set of two chemiluminescent detection probes each for detecting portions of amplified target sequence along with a dual photomultiplier tube detection system for simultaneous detection of the two chemiluminescent detection probes are also provided for practicing the invention, for use with a target specific set of amplification probes. Kits for practicing the invention are also provided.
    Type: Application
    Filed: February 8, 2001
    Publication date: July 25, 2002
    Inventors: Ann M. Morello, Qingping Jiang, John E. Monahan, Say-Jong Law
  • Publication number: 20020076823
    Abstract: Our results thus identify two sets of necessary and sufficient criteria for observing long-wavelength emission from acridinium compounds:
    Type: Application
    Filed: December 6, 2001
    Publication date: June 20, 2002
    Applicant: BAYER CORPORATION
    Inventors: Anand Natrajan, Qingping Jiang, David Sharpe, Say-Jong Law
  • Patent number: 6355803
    Abstract: This application relates to long-wavelength acridinium compounds having electron-donating groups, which may either be: (a) Part of an extended conjugation system attached by appropriate functional groups to the acridinium nucleus, with coplanarity of the attached functional group and the acridone moiety during light emission (geometry requirement), said functional group consisting of at least one aromatic ring and one electron-donating atom or group with an extra pair of electrons which can readily delocalize into the extended &pgr; system to which the heteroatom is directly attached or built into, and establish stable extended resonance with the electron-withdrawing carbonyl moiety of the light emitting acridone.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: March 12, 2002
    Assignee: Bayer Corporation
    Inventors: Anand Natrajan, Qingping Jiang, David Sharpe, Say-Jong Law
  • Patent number: 6165800
    Abstract: A new class of chemiluminescent acridinium or benzacridinium compounds is disclosed by virtue of forming an intramolecular energy transfer conjugate (ETC) between the acridinium or benzacridinium compound and a luminophore. A method of extending the emission wavelengths of acridinium or benzacridinium esters in order to further reduce or eliminate the emission spectral overlap between the parent polysubstituted aryl Acridinium Esters (DMAE) and Benzacridinium Esters (LEAE) is disclosed. The ETC's retain the unique desired properties of acridinium or benzacridinium compounds including complete light emission in very short period of time, monophasic emission spectrum, simplicity of triggering mechanism, ability of labeling the biological molecules of interest to form a tracer, and good stability. Additionally, the range of the emission spectrum of an acridinium or benzacridinium compound can now be shifted at will and at longer leap through the choice of a luminophore as the integral part of an ETC molecule.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: December 26, 2000
    Assignee: Bayer Corporation
    Inventors: Qingping Jiang, Jun Xi, Anand Natrajan, David Sharpe, Marcus Baumann, Rolf Hilfiker, Erika Schmidt, Paul Senn, Fritz Thommen, Adrian Waldner, Alex Alder, Say-Jong Law
  • Patent number: 5879894
    Abstract: An assay method incorporating at least two different chemiluminescent compounds for detection and/or quantitation of at least two substances in a test sample is described. The synthesis of chemiluminescent reagents or conjugates for use in such methods as well as kits incorporating such reagents are also disclosed. The assays have particular application in the field of clinical diagnostics.
    Type: Grant
    Filed: September 19, 1994
    Date of Patent: March 9, 1999
    Assignee: Chiron Diagnostics Corporation
    Inventors: Say-Jong Law, Qingping Jiang, Walter Fischer, John T. Unger, Elizabeth K. Krodel, Jun Xi
  • Patent number: 5702887
    Abstract: An assay method incorporating at least two different chemiluminescent compounds for detection and/or quantitation of at least two substances in a test sample is described. The synthesis of chemiluminescent reagents or conjugates for use in such methods as well as kits incorporating such reagents are also disclosed. The assays have particular application in the field of clinical diagnostics.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: December 30, 1997
    Assignee: Chiron Diagnostics Corporation
    Inventors: Say-Jong Law, Qingping Jiang, Walter Fischer, John T. Unger, Elizabeth K. Krodel
  • Patent number: 5656426
    Abstract: Novel acridinium esters that are useful, either alone or when incorporated into liposomes, as chemiluminescent agents in binding assays (e.g., immunoassays and gene probe assays) with improved-sensitivity are disclosed. In addition, the synthesis of these esters and their use in assays for detecting an analyte is described. In particular, assays for testosterone and the Rubella virus are disclosed.
    Type: Grant
    Filed: April 8, 1994
    Date of Patent: August 12, 1997
    Assignee: Chiron Diagnostics Corporation
    Inventors: Say-Jong Law, Chariklia Sotiriou-Leventis, Anand Natrajan, Qingping Jiang, Peter B. Connolly, John P. Kilroy, Constance R. McCudden, Stephen M. Tirrell
  • Patent number: 5395752
    Abstract: An assay method incorporating at least two different chemiluminescent compounds for detection and/or quantitation of at least two substances in a test sample is described. The synthesis of chemiluminescent reagents or conjugates for use in such methods as well as kits incorporating such reagents are also disclosed. The assays have particular application in the field of clinical diagnostics.
    Type: Grant
    Filed: March 19, 1993
    Date of Patent: March 7, 1995
    Assignees: Ciba Corning Diagnostics Corp., Ciba-Geigy A.G.
    Inventors: Say-Jong Law, Qingping Jiang, Walter Fischer, John T. Unger, Elizabeth K. Krodel